Educational materials on the risks of infusion reactions, medication errors associated with home infusions, and risks for pregnant women and women of reproductive potential during treatment with the medicinal product XENPOZYME (olipudase alfa)

09.01.2025 Updated 14.01.2025 784 views

Навчальні матеріали щодо ризиків виникнення інфузійних реакцій, медичних помилок, пов’язаних із проведенням інфузій у домашніх умовах, а також ризиків для вагітних та жінок з репродуктивним потенціалом під час лікування лікарським засобом КСЕНПОЗИМ (оліпудаза альфа)PDF · 172 КБ

Завантажити

Educational materials on the risks of infusion reactions, medication errors associated with home infusions, and risks for pregnant women and women of reproductive potential during treatment with the medicinal product XENPOZYME (olipudase alfa)

Forum "PHARMEXPERT 2026: pharmaceutical market in the new regulatory reality"

Forum "Clinical and preclinical studies in wartime: organization and development prospects"

Pharmaceutical forum "PHARMEXPERT 2025. eCTD and pricing in Ukraine – a strategic path to integration into the international regulatory space"

PHARMEXPERT 2024. Standards. Innovations. European integration

Educational materials on the risks of infusion reactions, medication errors associated with home infusions, and risks for pregnant women and women of reproductive potential during treatment with the medicinal product XENPOZYME (olipudase alfa)

Other materials in this section

Forum "PHARMEXPERT 2026: pharmaceutical market in the new regulatory reality"

Forum "Clinical and preclinical studies in wartime: organization and development prospects"

Pharmaceutical forum "PHARMEXPERT 2025. eCTD and pricing in Ukraine – a strategic path to integration into the international regulatory space"

PHARMEXPERT 2024. Standards. Innovations. European integration